Content about DSN AM

SILVER SPRING, Md. — The Food and Drug Administration on Tuesday announced that it has approved an amended application submitted by Teva Women’s Health to market Plan B One-Step (active ingredient levonorgestrel) for use without a prescription by women 15 years and older. The approval will move Plan B from behind the pharmacy counter into the family planning set of the pharmacy. 

MONTREAL — Stayhealthy on Tuesday announced the selection of BroadSign International as the company's digital signage software provider as it deploys its network of HealthCenter kiosks across the United States. BroadSign will manage Stayhealthy's rapid content deployment and network operations. 

SAVANNAH, Ga. — South University has appointed a new dean of its pharmacy school, the university announced.

Curtis Jones will oversee pharmacy programs for the South University School of Pharmacy in Georgia and South Carolina, reporting to vice chancellor of academic affairs Steven Yoho.

ROCHESTER, N.Y. — PharmaSmart International's blood-pressure screening program is in use in all the stores of a regional retail pharmacy chain in the Northeast.

PharmaSmart said it had deployed the peer-reviewed and clinically validated program at Kinney Drugs, which operates 97 stores in upstate New York and Vermont.

ALISO VIEJO, Calif. — A search feature that allows pharmacies to quickly determine why patients are calling so they can better serve their needs and a patient registration system that allows easier enrollment in medication-time reminders, disease management and smoking-cessation programs are among the new features of the latest version of PrescribeWellness' software system.

NEW YORK — Two Hy-Vee stores in Iowa will start composting food waste, produce and floral trimmings, according to published reports.

The Cedar Rapids, Iowa, Gazette reported that Hy-Vee stores in Iowa City and Cedar Rapids had partnered with Des Moines, Iowa-based organics recycler Green RU, which will pick up the waste from the stores and haul it to nearby compost centers. The newspaper reported that the company was considering whether to expand the pilot program throughout the chain.

HACKETTSTOWN, N.J. — Mars Chocolate, the makers of Snickers brand candy, announced today that the company is teaming up with jockey Rosie Napravnik as she attempts to make history in this weekend's Kentucky Derby race.

Mars Chocolate North America officially partnered with Rosie by announcing Snickers will give away 1 million Snickers Bites — which are unwrapped, bite-sized versions of the candy bar — if she wins the famous race on May 4.

WOONSOCKET, R.I. — The year appears to be off to a good start, and CVS Caremark executives were optimistic Wednesday morning as the company pulled in a “strong” first quarter and narrowed its 2013 guidance to reflect higher-than-expected performance.

HYDERABAD — The Food and Drug Administration has approved two generic drugs made by Aurobindo Pharma, the drug maker said.

The company announced Tuesday the approval of quinapril tablets in the 5-mg, 10-mg, 20-mg and 40-mg strengths. The drug is a generic version of Pfizer's Accupril and is used to treat high blood pressure. Various versions of the drug had sales of about $49 million during the 12-month period ending in September, according to IMS Health.

WOONSOCKET, R.I. — CVS Caremark announced that it was among several national companies represented at an event hosted on Tuesday by President Obama, VP Joe Biden, First Lady Michelle Obama and Dr. Jill Biden as part of the Joining Forces initiative.

During the event, the Administration asked companies participating in the Joining Forces initiative to hire and train 435,000 veterans and military spouses over the next five years, after nearly tripling its original goal of hiring 100,000 veterans and military spouses by the end of 2013.

SILVER SPRING, Md. — The Food and Drug Administration has approved a new treatment for a genetic disorder that affects about 500 people in the United States and 3,000 worldwide, the agency said Tuesday.

SILVER SPRING, Md. — The Food and Drug Administration has approved a drug that reverses the effects of anticoagulant drugs in patients who have suffered acute major bleeding, the agency said.

The FDA announced the approval of CSL Behring's Kcentra (prothrombin complex concentrate [human]) for the urgent reversal of vitamin K antagonist, or VKA drugs such as warfarin.